Trial Profile
Pregabalin BID [twice daily] open-label add-on trial: an open-label, multicenter follow-on study to determine long-term safety and efficacy in patients with partial seizures
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Sep 2006
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- 29 Sep 2006 Status change
- 19 Nov 2005 New trial record.